Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NPS shares halted as FDA panel reviews bowel drug
NPS shares halted as FDA panel reviews bowel drug
NPS shares halted as FDA panel reviews bowel drug
Submitted by
admin
on October 16, 2012 - 11:52am
Source:
Yahoo/AP
News Tags:
NPS Pharmaceuticals
FDA
advisory panels
Gattex
short bowel syndrome
Headline:
NPS shares halted as FDA panel reviews bowel drug
Do Not Allow Advertisers to Use My Personal information
